Previously, Aushon offered reverse phase array (RPA) print services through its custom microarray printing services, but has now added downstream array processing and data analysis.
These RPA arrays are particularly useful for high throughput analysis of protein levels and post-translational modifications, which in turn are key in biomarker identification and drug discovery programs.
Peter Honkanen, CEO of Aushon, said: “The goal of our new RPA processing service is to allow that group of scientist to benefit from this type of assay as well as reduce the risks of evaluating and adopting this technology.”